Shanmugam Muthusamy 的 Form 4/A 修正申報
修正Ani Pharmaceuticals Inc（ANIP），2023/6/23 申報
- 申報編號
- 0001104659-23-074399
- 申報時間
- 2023/6/23
- 交易日
- 2023/6/20-6/23
- 申報延遲
- 3 天
- 10b5-1 計畫
- 有勾選
- 原始申報日
- 2023/6/22
這份申報列了 4 筆非衍生性交易。公開市場賣出合計 $258.5 萬。交易後 3 天申報。
這份修正申報取代了 0001104659-23-073894（2023/6/22 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Shanmugam MuthusamyCIK 0001870913 | 董事、高階主管（HEAD OF R&D, COO-NOVITIUM OPS） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.63 to $52.80, inclusive. The reporting person undertakes to provide to ANIPharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 4, 5 and 6 to this Form 4.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.13 to $52.56, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.85 to $51.84, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.99 to $52.08, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The reporting person holds voting and dispositive power over the shares held by SS Pharma LLC.
備註
This Form 4, as originally filed, incorrectly reported the sales on June 20, 2023, June 21, 2023 and June 22, 2023 as shares held by the reporting person directly. The shares from such sales were held indirectly by the reporting person by Esjay LLC.